Market has been insane. ENG decided to go on a 300% plus run since I posted here so I sold half at 7.50 and seeing if it can still reach 10.
BCRX, my pick for the the portfolio just had an excellent presentation at jpm. Take a look at the slide deck. Factor D, 9930, has the makings of a blockbuster drug. They are adding indicatons to study including different nepropathies. Orledayo won't report sales until may earnings so don't buy this thinking you will get rich overnight. this will be a slow burner. but I think it could be at least a 2x to 3x stock this year and 10x plus over the next 2 to 4 years.
https://ir.biocryst.com/static-files/41ee0771-0acc-479e-a39e-2842101c6aa9
VXRT, oral covid vaccine is a company I added with cost basis of 5.70. It has already started running up because the phase 1 data is due by end of month. probably not too late yet. speculative buy of course. they are also working on an oral flu vaccine and the previous data on that leads me to believe phase 1 covid will have good results.